LAVA Therapeutics Stock (NASDAQ: LVTX) stock price, news, charts, stock research, profile.
Open | $2.930 |
Close | $3.000 |
Volume / Avg. | 103.909K / 1.092M |
Day Range | 2.900 - 3.050 |
52 Wk Range | 1.131 - 6.470 |
Market Cap | $79.406M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 1.21% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of LAVA Therapeutics (NASDAQ: LVTX) through any online brokerage.
There are no as such competitors for LAVA Therapeutics.
The latest price target for LAVA Therapeutics (NASDAQ: LVTX) was reported by HC Wainwright & Co. on Thursday, March 21, 2024. The analyst firm set a price target for 6.00 expecting LVTX to rise to within 12 months (a possible 98.64% upside). 7 analyst firms have reported ratings in the last year.
The stock price for LAVA Therapeutics (NASDAQ: LVTX) is $3.0205 last updated May 7, 2024 at 8:53 AM EDT.
There are no upcoming dividends for LAVA Therapeutics.
LAVA Therapeutics’s Q1 earnings are confirmed for Thursday, June 6, 2024.
There is no upcoming split for LAVA Therapeutics.
LAVA Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.